中国结核患者异烟肼漏服补救给药的模型引导精准给药
基于736例中国结核患者共1012个异烟肼浓度数据建立群体药代动力学模型,发现快、慢消除者表观清除率分别为28.0和11.2 L/h,快消除者占40.5%;蒙特卡洛模拟给出不同体重快慢消除者的最优剂量及漏服补救方案。
要点
- 异烟肼消除呈双速率,快消除者占40.5%,表观清除率28.0 L/h,慢消除者为11.2 L/h
- 漏服延迟不超过12小时应尽快补服,无需额外加量
- 漏服延迟超过12小时则仅按原方案正常服用下一剂即可
核心结论
- 群体药代动力学建模与模拟可为异烟肼精准给药及漏服补救方案提供有效证据。
研究设计与样本
- 纳入736例中国结核患者的1012个异烟肼浓度观察值,采用非线性混合效应模型分析群体药代动力学。
- 采用蒙特卡洛模拟确定最优剂量方案并设计漏服补救给药方案。
主要发现
- 二室模型含一级吸收和消除并以异速生长标度,可最佳描述异烟肼药代动力学特征。
- 混合模型刻画异烟肼双消除速率,快消除者表观清除率为28.0 L/h,慢消除者为11.2 L/h。
- 快消除者占人群比例估计为40.5%。
关键数值与推荐
- 蒙特卡洛模拟确定了不同体重慢消除者与快消除者的最优剂量方案。
- 漏服延迟不超过12小时应尽快补服,无需额外加量。
- 漏服延迟超过12小时,患者只需正常服用下一单次剂量。
临床怎么用
- 临床可依据患者体重及快慢消除表型参考模型模拟的最优剂量方案进行异烟肼精准给药。
- 对漏服患者按延迟是否超过12小时执行相应补救策略,避免不必要的额外给药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Isoniazid (INH) has been used as a first-line drug to treat tuberculosis (TB) for more than 50 years. However, large interindividual variability was found in its pharmacokinetics, and effects of nonadherence to INH treatment and corresponding remedy regime remain unclear. This study aimed to develop a population pharmacokinetic (PPK) model of INH in Chinese patients with TB to provide model-informed precision dosing and explore appropriate remedial dosing regimens for nonadherent patients. METHODS: In total, 1012 INH observations from 736 TB patients were included. A nonlinear mixed-effects modelling was used to analyse the PPK of INH. Using Monte Carlo simulations to determine optimal dosage regimens and design remedial dosing regimens. RESULTS: A 2-compartmental model, including first-order absorption and elimination with allometric scaling, was found to best describe the PK characteristics of INH. A mixture model was used to characterize dual rates of INH elimination. Estimates of apparent clearance in fast and slow eliminators were 28.0 and 11.2 L/h, respectively. The proportion of fast eliminators in the population was estimated to be 40.5%. Monte Carlo simulations determined optimal dosage regimens for slow and fast eliminators with different body weight. For remedial dosing regimens, the missed dose should be taken as soon as possible when the delay does not exceed 12 h, and an additional dose is not needed. delay for an INH dose exceeds 12 h, the patient only needs to take the next single dose normally. CONCLUSION: PPK modelling and simulation provide valid evidence on the precision dosing and remedial dosing regimen of INH.
引用
- Li JM, Zhang RY, Yang GY, et al. Model-based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosis. Br J Clin Pharmacol. 2024. PMID: 38570184. doi:10.1111/bcp.16050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。